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Abstract
Background: Gonadal steroids, in particular 5 alpha-dihydrotestosterone (DHT) and 17 beta-
estradiol (E2), have been shown to feed back on the hypothalamic-pituitary-gonadal (HPG) axis of
the ranid frog. However, questions still remain on how DHT and E2 impact two of the less-studied
components of the ranid HPG axis, the hypothalamus and the gonad, and if the feedback effects are
consistently negative. Thus, the goal of the study was to examine the effects of DHT and E2 upon
the HPG axis of the gonadally-intact, sexually mature male leopard frogs, Rana pipiens.
Methods: R. pipiens were implanted with silastic capsules containing either cholesterol (Ch, a
control), DHT, or E2 for 10 or 30 days. At each time point, steroid-induced changes in
hypothalamic GnRH and pituitary LH concentrations, circulating luteinizing hormone (LH), and
testicular histology were examined.
Results: Frogs implanted with DHT or E2 for 10 days did not show significant alterations in the
HPG axis. In contrast, frogs implanted with hormones for 30 days had significantly lower circulating
LH (for both DHT and E2), decreased pituitary LH concentration (for E2 only), and disrupted
spermatogenesis (for both DHT and E2). The disruption of spermatogenesis was qualitatively
similar between DHT and E2, although the effects of E2 were consistently more potent. In both
DHT and E2-treated animals, a marked loss of all pre-meiotic germ cells was observed, although
the loss of secondary spermatogonia appeared to be the primary cause of disrupted
spermatogenesis. Unexpectedly, the presence of post-meiotic germ cells was either unaffected or
enhanced by DHT or E2 treatment.
Conclusions: Overall, these results showed that both DHT and E2 inhibited circulating LH and
disrupted spermatogenesis progressively in a time-dependent manner, with the longer duration of
treatment producing the more pronounced effects. Further, the feedback effects exerted by both
steroid hormones upon the HPG axis were largely negative, although the possibility exists for a
stimulatory effect upon the post-meiotic germ cells.
Background
It is well established in mammals that gonadal steroid
hormones are potent negative feedback regulators of the
hypothalamic-pituitary-gonadal (HPG) axis. In ranid
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frogs, the first evidence supporting this notion came from
a study on the bullfrog, Rana catesbeiana, in which gona-
dectomy elevated circulating gonadotropins, and estrogen
and androgen replacement suppressed this elevation [1].
It was later shown that two gonadal steroids, 17β-estra-
diol (E2) and 5α-dihydrotestosterone (DHT), could
directly target the pituitary to modulate the release of
luteinizing hormone (LH) and follicle-stimulating hor-
mone (FSH) in these frogs [2-4].
Despite the established role of DHT and E2 as feedback
regulators of gonadotropin secretion in ranid frogs, there
is still some confusion regarding the exact nature of these
feedback effects. For example, in female and juvenile R.
catesbeiana, DHT suppressed the post-gonadectomy rise in
circulating gonadotropins [1], yet it enhanced the respon-
siveness of the pituitary to gonadotropin-releasing hor-
mone (GnRH) [1,5], suggesting DHT is involved in both
negative and positive feedback. On the other hand, in the
leopard frog (R. pipiens), DHT had no effect on the post-
castration rise in gonadotropin in males [2] but modestly
stimulated pituitary responsiveness to GnRH, suggesting a
role in only positive feedback. Although the effects of E2
were less variable, some conflicting data also exist. In both
R. catesbeiana and R. pipiens, E2 consistently inhibited LH
and FSH secretion both in vivo and in vitro, demonstrating
a direct and powerful negative feedback effect of E2 at the
level of the pituitary [1-3]. However, recent studies
reported E2 treatment significantly stimulated the prolifer-
ation of primary spermatogonia (I SPG) in the green frogs,
R. esculenta [6,7], suggesting an additional role of E2 in the
positive feedback of the HPG axis.
Results from the previous studies revealed the complex
nature in which estrogen and androgen feed back on the
reproductive axis, and suggest that the nature of the feed-
back effects might vary depending on the species, sex,
reproductive stage of the frogs used, and the duration of
steroid hormones administered. Further, there are still sig-
nificant gaps in our knowledge regarding how these two
steroid hormones feed back on the other two components
of the HPG axis, the hypothalamus and the gonad. There-
fore, the goal of the present study is to understand how E2
and DHT impact the HPG axis in gonadally-intact male R.
pipiens. We will do so by measuring parameters that reflect
the function of the HPG axis, including hypothalamic
GnRH, pituitary and circulating LH, and spermatogenic
activity. Moreover, steroid treatments were administered
over two periods, 10 days and 30 days, to examine if the
nature of steroidal feedback effects remains consistent
over time. These results should allow us to determine if
DHT and E2 act consistently as negative feedback regula-
tors at different levels of the HPG axis.
Methods
Animals
All experimental procedures were conducted in compli-
ance with the animal protocol approved by the Institu-
tional Animal Care and Use Committee at the University
of Colorado. Mature male northern leopard frogs, Rana
pipiens, were obtained from Carolina Biologicals (Burling-
ton, NC) from April to July of 2004. Since the life histories
of these animals were not entirely clear, all experiments
were conducted within the three-month period to mini-
mize the possible confounding effects of seasonality. As a
control, we performed histological analysis on testes of
representative frogs from every batch. When testicular his-
tology was compared, little differences were observed
among batches of frogs arriving at different times (data
not shown). Frogs were kept under a 12L:12D photope-
riod and fed live crickets every other day. All frogs were
allowed to acclimate to the laboratory environment for at
least one week before surgical implant.
Surgical Implant
One-cm silastic capsules containing crystalline cholesterol
(Ch: control), DHT, or E2 were prepared as previously
described [8], with some minor modifications. Briefly,
silastic tubing (outer diameter = 1.96 mm; inner diameter
= 1.47 mm) was filled with 1 cm length of crystalline Ch,
DHT, or E2 (Sigma, St Louis, MO) and sealed on both ends
with silicon glue. Ch implant was widely used as a nega-
tive control for the experimental treatment of cholesterol-
based compounds such as steroid hormones [8-11]. In a
preliminary observation (data not shown), we noted no
difference in the testicular morphology in animals that
have lost Ch capsules compared to animals that have
retained capsules throughout the 30-day period, indicat-
ing Ch had minimal effects on the reproduction of R. pip-
iens. Filled capsules were equilibrated in 0.6% saline for at
least 48 hours before implant. For implant, frogs were
anesthetized by immersion in 0.03% benzocaine. A small
incision was made at the base of the left leg and a silastic
capsule inserted subcutaneously. The incision was then
closed with silk thread. Frogs were monitored for recovery
from anesthesia and then returned to their respective
holding tanks.
Tissue Preparation
Ten or 30 days after implant, frogs were weighed and sac-
rificed by quick decapitation using a guillotine. Trunk
blood was collected into heparinized tubes, centrifuged,
and plasma stored at -70°C until the measurement of LH
and steroid hormones by radioimmunoassays (RIAs). Tes-
tes were removed, their masses recorded, and immersion-
fixed in Bouin's fixative overnight. Hypothalami were
excised from the brain by four cuts: a coronal cut 1 mm
rostral to the optic chiasm, a coronal cut on the caudal
border of the optic tectum, and two sagittal cuts along theReproductive Biology and Endocrinology 2005, 3:2 http://www.rbej.com/content/3/1/2
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lateral margins of the median eminence. Hypothalami
were flash-frozen on dry ice and stored at -70°C until
extraction and the measurement of GnRH by RIA. Pitui-
tary glands were removed, sonicated in 500 µl phosphate-
buffered saline (PBS), and stored at -70°C until the meas-
urement of LH by RIA. All carcasses were later inspected
for the presence of the silastic capsule in the legs. Animals
whose capsules were lost were excluded from data
analysis.
LH RIA
Plasma and pituitary LH levels were measured by a LH RIA
developed for the bullfrog (R. catesbeiana) [12] and vali-
dated for R. pipiens [13]. The iodination stock, standard,
and antiserum for the RIA were a generous gift of Dr. Paul
Licht (University of California at Berkeley). The limit of
detection was 0.1 ng/ml. The intra- and inter-assay coeffi-
cients of variation were 4.8% and 13.3%, respectively.
Pituitary LH levels were normalized for protein content
assessed by the Bradford protein assay (Bio-Rad Laborato-
ries, Inc., Hercules, CA).
Extraction of Hypothalami and GnRH RIA
Hypothalamic GnRH was extracted with 1 N HCl from the
frozen tissues as previously described [11]. The recovery
for hypothalamic extractions, assessed by the post-extrac-
tion counting of a known amount of [125I]GnRH added to
representative homogenates prior to extraction, was 86%.
GnRH RIA was carried out with an antiserum specific for
the mammalian form of GnRH (R1245, provided by Dr.
Terry Nett at the Colorado State University) using a proto-
col described in detail elsewhere [11,14,15]. The intra-
and inter-assay coefficients of variation were 7.3% and
5.0%, respectively. Hypothalamic GnRH levels were nor-
malized for protein content determined by the Bradford
protein assay.
Steroid Hormone RIAs
E2 and DHT RIAs were performed using the RIA kits from
Diagnostic Systems Laboratories (Webster, TX). These RIA
kits have been validated previously for the measurement
E2 and DHT in R. pipiens [11]. The limits of detection were
6.5 pg/ml for the E2 RIA and 4 pg/ml for the DHT RIA. The
intra- and inter-assay coefficients of variation were 5.3%
and 4.9%, respectively, for the E2 RIA, and 3.1% and
8.4%, respectively, for the DHT RIA. Both RIAs are highly
specific and cross-react minimally with other steroid
hormones.
Histology
After fixation, testes were dehydrated through ascending
concentrations of ethanol, defatted in Histoclear, and
embedded in paraffin. Thirteen-µm sections were cut on a
rotary microtome, mounted on poly-L-lysine-coated
slides, and stained with hematoxylin and eosin.
Immunocytochemistry (ICC) of Proliferating Cell Nuclear 
Antigen (PCNA)
Testes were processed for ICC of PCNA, a cell cycle S phase
marker, to identify I SPG and secondary spermatogonia
(II SPG) undergoing cell proliferation [16]. Testicular sec-
tions, prepared as described above for histological stain-
ing, were deparaffinized in Histoclear, rehydrated through
descending concentrations of ethanol, and immersed in
Antigen Unmasking Solution (Vector Laboratories, Burl-
ingame, CA) for 10 minutes at 90°C. After antigen
retrieval, sections were washed with 1% hydrogen perox-
ide in 0.1 M PBS containing 0.4% Triton × 100 (PBST) for
10 minutes to quench the endogenous peroxidase activity,
rinsed 5 times with PBST, and incubated for 48 hours at
4°C in PBST containing a monoclonal anti-PCNA anti-
body (Santa Cruz Biotechnology, Santa Cruz, CA; 1:500)
and 4% normal sheep serum. After incubation, sections
were washed with PBST and incubated with a biotinylated
sheep-anti-mouse IgG (Jackson Laboratory, West Grove,
PA; 1:400), washed, and incubated with the Vectastain
ABC reagent (Vector Laboratories) for 1 hour. Sections
were washed and the immunoreactivity visualized using
diaminobenzidine as the chromagen. After the color reac-
tion, sections were washed, counterstained with hematox-
ylin, dehydrated through ascending concentrations of
ethanol, cleared in Histoclear, and coverslipped. Controls
for ICC included the preadsorption of the primary antise-
rum with 20 µg/ml of recombinant human PCNA (Spring
Bioscience, Fremont, CA) and the omission of the primary
antiserum.
Histological Analysis
Five to eight testes (each from a different animal) per
treatment group were assessed for the following histolog-
ical parameters: seminiferous tubule diameter, the
number of I SPG per tubule, and the number of cysts
within each tubule containing II SPG, primary spermato-
cytes (I SPC), or secondary spermatocytes (II SPC). These
germ cells were defined according to Rastogi et al. [17]. To
score the number of cysts containing II SPG, I SPC, and II
SPC, sections stained with hematoxylin and eosin were
used. To score the number of I SPG, which were scattered
and more difficult to locate, sections processed for PCNA
ICC were used. Specifically, PCNA-positive cells that were
large, isolated, and located at the periphery of the cysts
were scored as proliferating I SPG. This method allowed
us to identify more I SPG than if morphological criteria
were used alone. Since most spermatids and mature sper-
matozoa were not confined within the cysts and were
therefore difficult to measure, these two germ cell types
were not quantified. For each testis, five randomly
selected tubules were sampled on a slide that had been
coded to conceal the identity of the animal. Histological
parameters from five tubules were averaged to give a mean
for a single animal. Tubular diameters were measuredReproductive Biology and Endocrinology 2005, 3:2 http://www.rbej.com/content/3/1/2
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using a calibrated ocular micrometer. All histological
parameters were assessed by one individual blind to the
identity of the slides.
Statistical Analysis
Differences among groups were analyzed by the one-way
analysis of variance (ANOVA) on log10-transformed data
followed by the Tukey's post-hoc test. Differences were
considered significant when P < 0.05.
Results
Steroid hormone RIAs were performed to monitor circu-
lating steroid hormone levels in Ch- and hormone-
implanted animals. For animals implanted for 10 days,
circulating E2 levels were 540 ± 110.5 (Ch group; n = 5)
and 1966 ± 13.2 pg/ml (E2 group; n = 5), and circulating
DHT levels were 0.9 ± 0.3 (Ch group; n = 4) and 37.5 ± 4
ng/ml (DHT group; n = 5). For animals implanted for 30
days, circulating E2 levels were 488 ± 370 (Ch group; n =
5) and 2255 ± 650 pg/ml (E2 group; n = 9), and circulating
DHT levels were 2.1 ± 1.4 (Ch group; n = 4) and 24.6 ± 2.7
ng/ml (DHT group; n = 8).
To assess the overall accumulation of GnRH in the
hypothalami of control and steroid hormone-treated ani-
mals, hypothalami were removed, extracted, and meas-
ured for the concentration of GnRH. No significant
differences in hypothalamic GnRH concentration were
observed among Ch, DHT, and E2 groups implanted for
10 or 30 days (Fig. 1). In animals implanted for 10 days,
plasma LH levels were not different among the treatment
groups (Fig. 2A). However, in animals implanted for 30
days, both DHT and E2 significantly suppressed circulat-
ing LH (Fig. 2B). The suppressive effect of E2 was signifi-
cantly more potent than DHT, with all E2-treated animals
having undetectable levels of circulating LH (Fig. 2B). In
10-day-implanted frogs, no differences in pituitary LH
concentration were observed among the treatment groups
(Fig. 3A). In 30-day-implanted frogs, E2, but not DHT, sig-
nificantly decreased the accumulation of LH in the pitui-
tary (Fig. 3B).
Testicular function was assessed by six parameters: the
gonadosomatic index (GSI; [g testes mass/g body mass] ×
100), the diameter of the seminiferous tubules, and the
presence of four germ cell types (I SPG, II SPG, I SPC, II
SPC) in the testes. Overall, no differences were observed
in any of the six parameters among treatment groups in
the 10-day-implanted animals (Fig. 4). However, in the
30-day-implanted animals, significant steroid-induced
changes in the testes were seen. E2 significantly depleted
the presence of I SPG, II SPG, I SPC, and reduced the GSI
(Fig. 5), whereas DHT significantly reduced only the pres-
ence of II SPG and I SPC (Fig. 5). Neither steroid hormone
affected the diameter of the seminiferous tubules or II SPC
(Figs. 5B, F). Representative photomicrographs of testicu-
lar histology (Fig. 6) showed morphological changes par-
allel to the quantitative measurements in Figs. 4 and 5. In
animals implanted for 10 days, no visible differences in
germ cell types were seen among treatment groups; I SPG,
II SPG, and I SPC were present equally in the testes of all
groups (Figs. 6A, B, C). In contrast, 30-day implant with
DHT or E2 resulted in highly pronounced and visible
changes in the histology of the testes (Figs. 6D, E, F).
Whereas Ch-treated tubules contained germ cells of all
Hypothalamic GnRH concentrations in implanted frogs Figure 1
Hypothalamic GnRH concentrations in implanted 
frogs. Hypothalamic GnRH concentrations in frogs 
implanted for (A) 10 days or (B) 30 days with either Ch, 
DHT, or E2. No significant differences were observed among 
treatment groups in either 10- or 30-day-implanted animals. 
Each bar represents mean ± SEM. N = 6–11.+
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types (Fig. 6D), DHT- and E2-treated tubules showed a
conspicuous absence of II SPG and I SPC (Figs. 6E, F). The
loss of I SPG with DHT and E2 treatments was less visible
than the loss of other two germ cell types (Figs. 6E, F), a
result consistent with the quantitative data (Fig. 5). Inter-
estingly, the formation of spermatozoa appeared to be
stimulated by DHT and E2; in fact, the most prominent
germ cells in tubules of DHT and E2-treated were the large
bundles of mature spermatozoa, which occupied most of
the tubular lumen (Figs. 6E, F).
PCNA ICC was conducted to determine the effects of
gonadal steroids on the number of proliferating germ cells
and to allow for the more consistent identification of I
SPG. In animals implanted with Ch, intense PCNA immu-
oreactivity was observed in both I SPG and II SPG. In addi-
tion, the cytoplasm of I SPC was lightly stained (Figs. 7A,
D), since PCNA was also shown to be expressed during
the pre-meiotic S phase and meiotic prophase [18]. All
spermatogonia (I SPG and II SPG) identifiable by the
hematoxylin counterstain were positive for PCNA. Treat-
ment with DHT (Fig. 7B) or E2 (Fig. 7C) did not visibly
alter the appearance of cells positive for PCNA in frogs
implanted for 10 days compared to the Ch control (Fig.
Plasma LH levels in implanted frogs Figure 2
Plasma LH levels in implanted frogs. Plasma LH levels in 
frogs implanted for (A) 10 days or (B) 30 days with either 
Ch, DHT, or E2. Each bar represents mean ± SEM. Dissimilar 
letters indicate significant difference between groups. ND = 
not detectable. N = 7–10.
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Pituitary LH concentrations in implanted frogs Figure 3
Pituitary LH concentrations in implanted frogs. Pitui-
tary LH concentrations in frogs implanted for (A) 10 days or 
(B) 30 days with either Ch, DHT, or E2. Each bar represents 
mean ± SEM. Dissimilar letters indicate significant difference 
between groups. N = 7–10.
Ch DHT E2
a
b
a
a
a
a
P
i
t
u
i
t
a
r
y
 
L
H
 
 
(
P
g
 
L
H
/
P
g
 
p
r
o
t
e
i
n
)
A
B
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
10-day
30-dayReproductive Biology and Endocrinology 2005, 3:2 http://www.rbej.com/content/3/1/2
Page 6 of 13
(page number not for citation purposes)
Testicular function in frogs implanted for 10 days Figure 4
Testicular function in frogs implanted for 10 days. Measurements of testicular function in frogs implanted for 10 days 
with either Ch, DHT, or E2. (A) Average GSI, (B) average diameter of seminiferous tubules, (C) number of I SPG, and number 
of cysts containing (D) II SPG, (E) I SPC, and (F) II SPC were measured from 5–8 animals per treatment group. Each bar rep-
resents mean ± SEM. ND = not detectable. No significant differences were observed among treatment groups in any of the 
parameters measured.
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Testicular function in frogs implanted for 30 days Figure 5
Testicular function in frogs implanted for 30 days. Measurements of testicular function in frogs implanted for 30 days 
with either Ch, DHT, or E2. A) Average GSI, (B) average diameter of seminiferous tubules, (C) number of I SPG, and number 
of cysts containing (D) II SPG, (E) I SPC, and (F) II SPC were measured from 5–6 animals per treatment group. Each bar rep-
resents mean ± SEM. Dissimilar letters indicate significant difference between groups.
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Testicular histology of implanted frogs Figure 6
Testicular histology of implanted frogs. Representative testicular histology of frogs implanted with (A, D) Ch, (B, E) 
DHT, or (C, F) E2. (A, B, C) Testes from animals implanted for 10 days. (D, E, F) Testes from animals implanted for 30 days. 
Red arrow = I SPG; dark blue arrow = II SPG; light blue arrow = I SPC; yellow arrow = II SPC; green arrow = spermatozoa. 
Note DHT and E2 had no visible effects on testes of animals implanted for 10 days (A, B, C). In contrast, DHT and E2 visibly 
altered the germ cell composition in animals implanted for 30 days (D, E, F). Note the prominent spermatozoa and the 
absence of I SPC and II SPG in both DHT- and E2-treated testes (E, F). Scale bar = 100 µm.
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7A). In contrast, in animals implanted for 30 days, a visi-
ble reduction in the number of PCNA-positive germ cells
was observed in DHT- and E2-treated animals (Figs. 7E, F)
compared to the Ch control (Fig. 7D). This reduction was
primarily due to the decreased presence of I SPG, II SPG,
and I SPC in the testes treated with steroid hormones. In
control sections incubated with preadsorbed primary
antiserum or no primary antiserum, only background
staining was present (data not shown).
Discussion
Under our experimental paradigm, both E2  and DHT
exerted negative feedback effects upon the reproductive
axis of the sexually mature male leopard frogs. The mani-
festation of these inhibitory effects was time-dependent
and required treatment duration for longer than 10 days.
In frogs implanted for 30 days, E2 decreased circulating LH
to undetectable levels and significantly reduced the pres-
ence of I SPG, II SPG, and I SPC. The effects of DHT were
less potent, reducing only circulating LH, II SPG, and I
SPC. Unexpectedly, the presence of post-meiotic germ
cells was either unaffected or stimulated with the DHT or
E2 treatment. These results suggest that along the repro-
ductive axis, the most significant negative feedback effects
were upon the pituitary and testes, although a stimulatory
effect upon the testes might also exist.
All hormone implants elevated circulating steroid hor-
mones to levels above the Ch controls without exceeding
the physiological range reported for male ranid frogs. For
instance, depending on the reproductive status, the range
of circulating E2 reported for sexually mature male ranid
frogs was approximately 100 to 3500 pg/ml, and the range
of circulating DHT was approximately 1 to 30 ng/ml
[6,19]. Another study [20] reported circulating levels of
approximately 10 ng/ml for DHT and 2 ng/ml for E2 in
captive male R. pipiens. Thus, circulating E2 and DHT in
the hormone-implanted animals were largely within the
high end of the physiological range.
DHT and E2  did not significantly alter hypothalamic
GnRH concentration in animals treated for 10 or 30 days.
These results were consistent with our previous finding on
frogs implanted for 20 days with DHT and E2, and speak
to the highly stable nature of GnRH peptide accumula-
tion. One should note that this study focused on the
mammalian form (Type I) of GnRH because this is the
predominant hypophysiotropic form of GnRH in the
diencephalon of ranid frogs [21] and the form more sen-
sitive to changes in reproductive status [22]. However, the
chicken II (Type II) form of GnRH may also be hypophys-
iotropic since it binds to pituitary GnRH receptor with
high affinity [23], and its presence is detected in the
hypothalamic-pituitary portal blood [21]. The ability of
steroid hormones to feed back upon the Type II GnRH
system in R. pipiens is at present unclear and awaits further
investigation.
Only E2 treatment for the longer duration (30 days) signif-
icantly reduced pituitary LH concentration, although a
substantial amount of LH still remained in the pituitary
glands of these E2-treated animals. Thus, the potent sup-
pression of circulating LH in animals treated with E2 for
30 days was most likely attributable to the low secretory
activity of the pituitary gonadotropes rather than the
depletion of LH stores. Somewhat surprising was the ina-
bility of E2 treatment for 10 days to suppress circulating
LH. The pituitaries of ranid frogs were shown to be
extremely sensitive to the inhibitory actions of E2. In R.
pipiens, in vitro exposure of the pituitary to E2 concentra-
tions as low as 100 pg/ml for only 48 hours significantly
suppressed both basal and GnRH-stimulated gonadotro-
pin secretion [2]. Extrapolating from this time course and
from our current observation that E2 implants could ele-
vate circulating E2 to about 2000 pg/ml, one might expect
a substantial decline in circulating LH of these animals
after only 10 days of implant, but this was not the case. It
is possible that additional in vivo mechanisms exist in
these frogs to buffer against short-term estrogenic inhibi-
tion. Some of these might include changes in the clear-
ance rate of circulating LH [24] and the levels of sex
steroid binding proteins [25]. The former could prolong
the half-life of LH in circulation; the latter could dampen
the inhibitory effects of E2 by binding to E2 and decreasing
the availability of the bioactive hormone.
Another unexpected observation was that DHT treatment
for 30 days also suppressed circulating LH. Our results dif-
fer from a previous study demonstrating the inability of
DHT to suppress post-gonadectomy rise in LH [2] and
showed, for the first time, that DHT participates in the
negative feedback regulation of gonadotropin secretion in
R. pipiens. It is at present unclear if reduced circulating LH
is a direct consequence of suppressed secretory activity of
the gonadotropes or reduced output from the GnRH sys-
tem. Based on the previous report that DHT had no direct
inhibitory effect on pituitary gonadotropin secretion [2],
it seems likely that DHT may achieve negative feedback
primarily by targeting the GnRH system to suppress
GnRH release. This possibility does not conflict with our
current observation that DHT lacks an effect on GnRH
content. Since GnRH content is a measure of GnRH pep-
tide accumulation which is a result of transcription, trans-
lation, mRNA stability, peptide turnover, or release, it is a
poor indicator of GnRH release alone.
One of the most pronounced negative feedback effects of
DHT and E2 was observed at the level of the testes. In ani-
mals implanted for 30 days with these two steroids, a
marked loss of several germ cell types (I SPG, II SPG, andReproductive Biology and Endocrinology 2005, 3:2 http://www.rbej.com/content/3/1/2
Page 10 of 13
(page number not for citation purposes)
PCNA ICC on testes of implanted frogs Figure 7
PCNA ICC on testes of implanted frogs. Representative photomicrographs of PCNA ICC performed on testicular sec-
tions of frogs implanted with (A, D) Ch, (B, E) DHT, or (C, F) E2. (A, B, C) Testes from animals implanted for 10 days. (D, 
E, F) Testes from animals implanted for 30 days. Brown stain = PCNA immunoreactivity. Blue stain = hematoxylin counter-
stain. Red arrow = I SPG; dark blue arrow = II SPG; light blue arrow = I SPC. Note DHT and E2 had no visible effects on testes 
of animals implanted for 10 days (A, B, C). In contrast, DHT and E2 visibly reduced the presence of PCNA-positive germ cells 
in animals implanted for 30 days (D, E, F). Σχαλεβαρ = 100 µm.
10-day 30-day
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I SPC) was observed. Interestingly, although E2 exerted a
greater disruptive effect on spermatogenesis, similar
trends of reduction with virtually no qualitative difference
were also observed in DHT-treated testes, suggesting sim-
ilar outcome might be attained with longer DHT
exposure. That DHT- and E2-induced disruption of sper-
matogenesis differed only in the degree of severity sug-
gests the disruption occurred primarily via a common
pathway, possibly through the inhibition of gonadotro-
pins. In this study, we could not measure circulating FSH
because we lack a homologous FSH RIA. However, previ-
ous studies have reported that FSH secretion in R. pipiens
was under the negative control of E2 [2,3] and possibly
DHT [2], since gonadectomy significantly elevated the lev-
els of circulating FSH. The observation that spermatogenic
disruption occurred only when circulating gonadotropin
was reduced (30 day-implants) further lends support to
this hypothesis.
Although the roles of FSH and LH in anuran spermatogen-
esis are not entirely clear, data from other amphibians
suggest FSH is essential for supporting the proliferation
and survival of spermatogonia [26,27]. Importantly, FSH
is required for the completion of the last spermatogonial
mitosis, thus the entrance into meiosis and the generation
of spermatocytes [27]. On the other hand, LH is specifi-
cally required for the stimulation of androgen production
in ranid frogs [28] and could be responsible for maintain-
ing high levels of intratesticular androgen required for
androgen-dependent stimulation of germ cell formation
[29]. Thus, low circulating levels of gonadotropins could
be the common pathway leading to defective sperma-
togenesis in both DHT- and E2-treated animals. Although
the significant reduction of I SPG in E2-treated testes could
partially account for the loss of germ cell types that arose
from I SPG, this cannot be the sole cause. For example,
substantial PCNA-positive I SPG still remained in the tes-
tes of frogs implanted with E2 for 30 days, yet virtually no
II SPG remained in the testes of these animals. Similarly,
in 30-day-DHT-treated testes, there was no significant
decline in I SPG, but II SPG were markedly reduced. These
observations indicate a disproportionate loss of II SPG
that may have resulted from their failure to survive. These
data were consistent with a previous report in the newt
that the mitotic penultimate SPG failed to survive when
circulating FSH was suppressed [26]. Taken together, we
believe that II SPG was the germ cell type most severely
affected by steroid treatments, and the loss of II SPG was
the most important underlying cause for disrupted
spermatogenesis.
An interesting observation is that although pre-meiotic
germ cells (I SPG, II SPG, and I SPC) were adversely
affected by steroid hormone implants at 30 days, meiotic
or post-meiotic germ cells (II SPC, spermatids and sper-
matozoa) appeared unaffected or stimulated. In fact, the
most conspicuous germ cells in the seminiferous tubules
of 30-day E2- or DHT-implanted frogs were mature
spermatozoa, which occupied the largest bulk of the tubu-
lar lumen. It is possible that low circulating FSH had little
influence on the germ cells once they entered meiotic divi-
sion. Under low circulating LH, spermiation was inhib-
ited, and mature spermatozoa continued to accumulate in
the tubule. Another possibility is that E2 and DHT, while
suppressing the presence of pre-meiotic germ cells, actu-
ally stimulated the entrance of existing I SPC into meiosis
and promoted the survival of post-meiotic germ cells. This
possibility was partially supported by the previous obser-
vation that testes of frogs treated with DHT for 20 days
had fewer II SPG, but significantly more I SPC in the midst
of meiotic division [11]. Along the same line of reasoning,
it is also possible that DHT and E2 facilitated the progres-
sion of spermatogenesis to the extent that the intermedi-
ate germ cell types could no longer be adequately
replenished, leaving tubules filled with post-meiotic cells
(primarily spermatozoa) and very little else. Regardless,
the trend towards reduced GSI in steroid hormone-treated
animals, along with the reduced presence of pre-meiotic
germ cells, indicate an overall negative effect of these hor-
mones upon the testes. The abundance of spermatozoa in
DHT- and E2-treated animals nevertheless raised an inter-
esting possibility for the existence of a positive steroidal
effect on spermatogenesis.
Worth mentioning is the possibility that DHT and E2, in
addition to affecting spermatogenesis by lowering
circulating gonadotropins, have also been shown to act
directly upon the amphibian testes. Both androgen and
estrogen binding sites were found in the amphibian testes
[30-33]. A number of physiological responses were pre-
sumably mediated through these testicular steroid hor-
mone receptors. For instance, E2 acted directly upon the
amphibian testes to suppress androgen secretion [34-36],
stimulate nuclear translocation of c-Fos [37,38], and
enhance proliferation of I SPG [6,37]. Similarly, DHT has
also been found to directly modulate androgen secretion
[34]. Of interest to the present study is the demonstration
that E2 directly stimulated SPG I proliferation in R. escu-
lenta  [6,7,37]. Under our experimental paradigm,
however, such a stimulatory effect was not seen in R. pipi-
ens. Whether or not this discrepancy was due to the differ-
ences in experimental paradigms or species used is at
present unclear.
We previously showed that spermatogenesis in the ranid
frogs was altered in mature male frogs implanted with
DHT and E2 for 20 days [11]. Specifically, E2 reduced the
presence of II SPG and I SPC, whereas DHT reduced only
the presence of the former. However, the study repre-
sented only a snapshot in time, so no information wasReproductive Biology and Endocrinology 2005, 3:2 http://www.rbej.com/content/3/1/2
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available regarding the progression of events that led to
the altered formation of germ cells. Moreover, it was
unclear if the treatment with these two steroid hormones
for shorter or longer periods could impact the testes
differently. Our current results showed that both steroids
inhibited circulating gonadotropin and disrupted sperma-
togenesis progressively in a time-dependent manner, with
the longer duration of treatment producing the more pro-
nounced effects. Further, the changes in the testes were
qualitatively similar between DHT and E2 treatments, sug-
gesting declining gonadotropin levels might be the com-
mon underlying cause for the disrupted spermatogenesis.
These results reflect the highly sensitive nature of the
anuran reproductive axis to estrogenic and androgenic
modulation. We showed that the continuous exposure of
mature frogs to high physiological levels of steroid hor-
mones for a relatively short period could profoundly alter
their pituitary and testicular function. In particular, the
potency of estrogen hormones raises concerns regarding
the potential reproductive disruption that can occur when
mature frogs are exposed to short-term and low-level envi-
ronmental estrogen mimics.
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